Jacob Kaiserman
Overview
Explore the profile of Jacob Kaiserman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mercado N, Real J, Kaiserman J, Panagioti E, Cook C, Lawler S
NPJ Precis Oncol
. 2024 Sep;
8(1):213.
PMID: 39343770
Glioblastoma (GBM) is one of the deadliest brain cancers with a median survival of only 15 months. This poor prognosis has prompted exploration of novel therapeutic targets for GBM patients....
2.
OHara B, Lukacher A, Garabian K, Kaiserman J, MacLure E, Ishikawa H, et al.
PLoS Pathog
. 2024 Jul;
20(7):e1012335.
PMID: 39038049
The human polyomavirus JCPyV is an opportunistic pathogen that infects greater than 60% of the world's population. The virus establishes a persistent and asymptomatic infection in the urogenital system but...
3.
Kaiserman J, OHara B, Haley S, Atwood W
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37239927
Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease caused by infection with JC Polyomavirus (JCPyV). Despite the identification of the disease and isolation of the causative pathogen over fifty...
4.
Kaiserman J, OHara B, Garabian K, Lukacher A, Haley S, Atwood W
mBio
. 2023 Feb;
14(2):e0358322.
PMID: 36786589
JC polyomavirus (JCPyV) is a ubiquitous, double-stranded DNA virus that causes the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML) in immunocompromised patients. Current treatments for PML are limited to immune...